Home/The author
Professor of Medical Genetics · Author
Prof. Dr. Abdimajid Nur Osman
Cabdimajiid Nuur Cismaan
A professor of medical genetics and inherited disease, with 23 years at Linköping University Hospital and pioneering genome research on the Somali population.
25+
Peer-reviewed articles
23
Years in clinical genetics
18
Journals he reviews for
2016–22
Somali genome research
Biography
A life in genetics
Prof. Abdimajid Nur Osman (Cabdimajiid Nuur Cismaan) is a professor of medical genetics and inherited disease. He settled in Sweden in 1986, earned his B.Sc. (1994) and M.Sc. (1996) at the University of Gothenburg, and completed his PhD in medicine at Linköping University in 2007.
He has worked at Linköping University and the University of Cambridge, and spent 23 years at Linköping University Hospital as a clinical scientist specialising in human genetic disorders. From 2014 he was Associate Professor of Medical Genetics at Linköping University, and since 2023 he has directed Cidlogenomics, a consultancy for genomic medicine.
His research spans the links between DNA and disease, pharmacogenomics and population genetics — including genome-wide studies of the Somali population carried out between 2016 and 2022. Isirka DNA ee Soomaalida is his first book written in Somali.
Career & education
The journey
2023 – present
Director
Cidlogenomics, Linköping
Consultancy specialising in genomic medicine.
2018 – 2022
Adjunct Professor of Clinical Biochemistry
Linköping University Hospital
Professorship linked to his clinical position at the hospital.
2014 – 2022
Associate Professor of Medical Genetics
Faculty of Medicine, Linköping University
Principal investigator in medical genomics and pharmacogenomics.
2009 – 2018
Senior Lecturer
Faculty of Medicine, Linköping University
Taught medical genetics and medical bioinformatics; supervised PhD and master's students.
1999 – 2022
Senior Clinical Scientist
Linköping University Hospital
Department of Laboratory Medicine — expertise in human genetic disorders.
2008
Post-doctoral research
University of Cambridge, Department of Haematology
UK-wide research on genetic markers for cardiovascular disease.
1998 – 1999
Research Biochemist
AstraZeneca, Gothenburg
2003 – 2007
PhD, Clinical Biochemistry / Pharmacogenomics
Linköping University
Thesis on inter-individual variation in warfarin treatment.
1994 – 1996
M.Sc. in Biochemistry
University of Gothenburg
1990 – 1994
B.Sc. in Biomedical Sciences
University of Gothenburg
Books
Written by Abdimajid Nur Osman
Selected research
Scientific publications
2022
2020
2017
2020
2019
2018
2018
2016
2015
2015
2014
2014
2013
2013
2012
2012
2011
2010
2009
2008
2008
2007
2006
2005
1997
Cross-ethnic analysis of common gene variants in hemostasis show lopsided representation of global populations in genetic databases
BMC Medical Genomics · Featured
Genome-wide analyses disclose the distinctive HLA architecture and the pharmacogenetic landscape of the Somali population
Scientific Reports · Featured
Prevalence of common hereditary risk factors for thrombophilia in Somalia and identification of a novel Gln544Arg mutation in coagulation factor V
Journal of Thrombosis and Thrombolysis · Featured
Platelet pathogen reduction technologies alter the microRNA profile of platelet-derived microparticles
Frontiers in Cardiovascular Medicine
Assessment of genetic and non-genetic risk factors for venous thromboembolism in glioblastoma — the predictive significance of B blood group
Thrombosis Research
Frequency of PAR4 Ala120Thr variant associated with platelet reactivity significantly varies across sub-Saharan African populations
Blood
The platelets' perspective to pathogen reduction technologies
Platelets
Peculiarities of studying the effects of pathogen reduction technologies on platelets
Proteomics Clinical Applications
Differential expression analysis by RNA-Seq reveals perturbations in the platelet mRNA transcriptome triggered by pathogen reduction systems
PLOS ONE
Effects of pathogen reduction systems on platelet microRNAs, mRNAs, activation, and function
Platelets
Influence of UGT2B7, OPRM1 and ABCB1 gene polymorphisms on morphine use
Basic & Clinical Pharmacology & Toxicology
miR-20b regulates expression of PAR-1 thrombin receptor in melanoma cells
Pigment Cell & Melanoma Research
Next generation sequencing analysis of human platelet PolyA+ mRNAs and rRNA-depleted total RNA
PLOS ONE
Exon resequencing of the gene encoding UCma/GRP reveals a common carboxy-terminal 138Thr > Ser polymorphism
Clinical Laboratory
MicroRNAs in health and disease — basic science and clinical applications
Clinical Laboratory
The role of thrombin receptors PAR1 and PAR4 for PAI-1 storage, synthesis and secretion by human platelets
Thrombosis Research
Characterization of human platelet microRNA by quantitative PCR coupled with an annotation network for predicted target genes
Platelets
The VKORC1 promoter is occupied by c-Myc transcription factor in HepG2 cells
Thrombosis Research
Plasma predilution with addition of depleted plasma in a prothrombin time reagent improves the agreement between different prothrombin time methods
Scandinavian Journal of Clinical and Laboratory Investigation
A possible ethanol-catalyzed rearrangement of vitamin K1 detected by gas chromatography/mass spectrometry
Rapid Communications in Mass Spectrometry
A genotyping method for VKORC1 1173C>T by Pyrosequencing technology
Scandinavian Journal of Clinical and Laboratory Investigation
Plasma S/R ratio of warfarin co-varies with VKORC1 haplotype
Blood Coagulation & Fibrinolysis
Main haplotypes and mutational analysis of vitamin K epoxide reductase (VKORC1) in a Swedish population
Journal of Thrombosis and Haemostasis
A new high-performance liquid chromatographic method for determination of warfarin enantiomers
Journal of Chromatography B
Effects of metal ions on the substrate-specificity and activity of proton-pumping nicotinamide nucleotide transhydrogenase from Escherichia coli
Biochimica et Biophysica Acta